NORML

MARCH 1, 2019

Barbara Lee (D-CA) asked US Food and Drug Commissioner Scott Gottlieb whether he believed that it is possible for a US-based company to bring a marijuana plant-derived drug to market in light of the existing federal prohibitions on licensing. .” ” The APA represents nearly 120,000 researchers and clinicians.

DEA 182

DEA Research and Development Clinical Trials Marijuana 182

Cannabis Law Report

MARCH 30, 2019

The trials, to be tightly controlled in a hospital environment, are exempted from Japan’s Cannabis Control Act, which bans cannabis compounds generally. Food and Drug Administration last year. Japanese officials approve Epidiolex for clinical trials.

Clinical Trials 45

Clinical Trials Research and Development Epilepsy Environment 45

SpeedWeed

MAY 15, 2021

A first-of-its-kind Phase 3 clinical trial has found that MDMA-assisted therapy provided meaningful relief from PTSD symptoms in nearly 90 percent of study participants. The post Final Phase of MDMA Clinical Trials Shows Drug Is 90% Effective at Treating PTSD appeared first on SpeedWeed. Image via.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Otherside Farms

JANUARY 24, 2019

Food and Drug Administration (FDA) may approve more as the studies progress. Aside from considerable anecdotal evidence suggesting marijuana’s efficacy in treating epilepsy, the company won regulatory approval with nearly five years of pre-clinical trial data — with more studies to come. “In In the upcoming U.S.

Clinical Trials 45

Clinical Trials Epilepsy Marijuana Pharmaceutical 45

Project CBD

JANUARY 31, 2023

The announcement is riddled with disingenuous doublespeak, starting with the wordy title: “FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward.” So it’s passing the buck to Congress.

CBD 130

CBD Clinical Trials Pharmaceutical Food 130

NewsMunchies

DECEMBER 13, 2021

In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. Food and Drug Administration.

Clinical Trials 95

Clinical Trials Therapy Decriminalization Patients 95

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. Quite frankly, the clinical trials couldn’t have come at a better time. About the Opioid Epidemic. This process involves feeding the nutrient-dense aquaculture water to hydroponically cultivated plants.

Clinical Trials 116

Clinical Trials Chronic Pain Hydroponic Strains 116

Cannabis Law Report

AUGUST 16, 2021

The tasty, and fast acting My True 10 CBD watermelon flavored gummies are different from many products in the CBD category as they are backed by extensive research and clinical trials. Not all CBD is made equal, as seen with the high-quality ingredients and thoughtful innovation in the My True 10 gummies.

Food 81

Food CBD Research and Development Clinical Trials 81

Veriheal

JUNE 29, 2022

While 233 participants might sound low, it is still the largest number of humans to participate in a psilocybin-based clinical trial. It’s rare to see such positive outcomes of clinical trials in this disease area, which is why these results are so significant. Food and Drug Administration (FDA) for the treatment of TRD.

Clinical Trials 105

Clinical Trials Blood Pressure Treatment Therapy 105

Medical Marijuana Program Connection

JANUARY 31, 2024

Lexaria Bioscience Corporation, a global innovator in drug delivery platforms, announced that on January 29 it has submitted its much-anticipated Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) for its planned US phase 1b hypertension clinical trial HYPER-H23-1 of DehydraTECH-CBD.

Clinical Trials 69

Clinical Trials CBD Food 69

Cannabis Law Report

DECEMBER 2, 2021

(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.

Clinical Trials 40

Clinical Trials Data Patients THC 40

Cannabis Law Report

AUGUST 3, 2021

Food and Drug Administration, Health Canada or other similar regulatory authorities have not evaluated claims regarding psilocybin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds or nutraceutical products. Vigorous scientific research and clinical trials are needed.

Clinical Trials 105

Clinical Trials Events Treatment Banking 105

Cannabis Law Report

JANUARY 4, 2022

Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for the clinical trial evaluating Nantheia™ ATL5, an investigational drug using cannabidiol (CBD) in ANANDA’s proprietary delivery technology as an Adjunctive Treatment for Opioid Use Disorder.

Clinical Trials 40

Clinical Trials Treatment Research and Development Media 40

Veriheal

OCTOBER 20, 2023

In August, DWCD employees connected with the United Food and Commercial Workers Union (UFCW). Food and Drug Administration (FDA) issued new guidelines supporting the research and development of psychedelic-based drugs. With the UFCW’s help, DWCD workers had enough momentum to schedule a vote. In June, the U.S.

Policy 110

Policy Clinical Trials Research and Development Dispensary 110

Cannabis Law Report

JULY 28, 2021

This includes First Time in Human (“FTiH”) clinical trials, which are expected to commence in 2022, for the Group’s lead compound OCT461201, a selective cannabinoid receptor type 2 (“CB2”) agonist with initial indications in the areas of post herpetic neuralgia and visceral pain caused by irritable bowel syndrome.

Cannabinoids 81

Cannabinoids Clinical Trials Safety Medicine 81

Project CBD

FEBRUARY 28, 2023

Under section 201(ff)(3)(B) of the Federal Food, Drug, and Cosmetic Act — in what some refer to as the “drug preclusion clause” 4 — any substance that is an active ingredient in an approved drug product, or that is being publicly investigated as such, is excluded from the definition of a legal dietary supplement ingredient. 2021;56:530-543.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

AUGUST 14, 2021

“Satipharm CBD products are currently sold over-the-counter at major pharmacies and health food retailers in the UK and Cann is in discussions with major healthcare companies in relation to global distribution rights to the product.”

CBD 105

CBD Clinical Trials Programs Medicine 105

Veriheal

JUNE 30, 2023

For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial. The 13 individuals were chosen because of their reported improvements in negative drinking behavior following the clinical trial. Let us know in the comments!

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

OCTOBER 6, 2021

(NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally.

Clinical Trials 40

Clinical Trials Research and Development Pharmaceutical Events 40

The Cannigma

MARCH 7, 2022

A 2012 study in rats compared the effects of CBD, CBG, and CBN on food consumption and showed that unlike the others, CBN increased feeding. What can the current clinical trials tell us? CBD actually decreased feeding, while CBG had no effect.

THC 140

THC Clinical Trials Sleep Cannabinoids 140

Cannabis Law Report

JUNE 17, 2021

Brains is one of a few companies in the world producing CBD as an API for pharmaceutical applications, research, development, and clinical trials. The Brains partnership with DSM Venturing will allow the company to take advantage of strategic partnerships that DSM has developed since their initial inception in 1902.

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Events 105

Cannabis Law Report

AUGUST 10, 2021

These promising results will likely lead to psychedelic-assisted mental health treatments becoming approved by the US Food and Drug Administration (FDA) upon completion of the ongoing clinical trials.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Cannabis Law Report

AUGUST 29, 2019

Not only that, but what about foods and dietary supplements containing CBD derived from hemp? The uncertainty is even greater for the host of CBD-containing products that are likely cosmetics under the Food, Drug & Cosmetic Act. But what about CBD that is derived from hemp in view of its removal from the controlled substance list?

Food 45

Food Hemp CBD Clinical Trials 45

Cannabis Law Report

AUGUST 19, 2021

Britain’s Food Standards Agency now regulates the sector and its marketing, after the European Union classified CBD as food in 2019. Faced with booming sales, professor Sagnik Bhattacharyya, who researches psychotic and substance abuse disorders at King’s College London, says clinical trials are needed.

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

Cannabis Law Report

JUNE 20, 2021

LeafCann ’s mission is to advance the re-introduction of plant-based extracts in medicine and nutrition through conducting and supporting product and industry research and development, clinical trials, commercial production, and GMP manufacturing.

Supply Chain 81

Supply Chain Clinical Trials Research and Development Medicine 81

Cannabis Law Report

AUGUST 17, 2021

Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. Food and Drug Administration (FDA) has granted orphan drug designation to ganaxolone in TSC. Conference call and webcast to be held today at 4:30 p.m. RADNOR, Pa.–(BUSINESS Conference Call and Webcast Details.

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

The Blunt Truth

DECEMBER 23, 2020

In quick succession, the Food & Drug Administration (FDA) announced yesterday, December 22 nd , that it issued five warning letters to companies for selling products containing CBD in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). Actions Speak Louder Than Words.

CBD 103

CBD Food Safety Clinical Trials 103

Veriheal

JUNE 12, 2025

In January, the US Food and Drug Administration (FDA) approved the Johnson & Johnson brand nasal spray, Spravato®, as the world’s first and only monotherapy for addressing treatment-resistant cases of major depressive disorder (MDD). However, tolerance may still occur because of reduced responses to prolonged treatment.

Therapy 69

Therapy Treatment Clinical Trials Blood Pressure 69

Cannabis Law Report

AUGUST 12, 2021

Phase IIb clinical trial of COMP360 psilocybin therapy for TRD close to completion. Business highlights. COMP360 psilocybin therapy has now been given to 233 patients, exceeding 216 target. On track to report top-line data by end of 2021. We are headquartered in London, UK, with offices in New York, US.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

JUNE 30, 2021

LONDON–(BUSINESS WIRE)– Fourfive , the CBD and nutrition brand loved by athletes and those leading an active lifestyle, today called on the UK’s sports governing bodies to stop sitting if on the fence and conduct clinical trials into the effectiveness of CBD and medicinal cannabis in professional sport.

Medicine 75

Medicine Clinical Trials CBD Sleep 75

Cannabis Law Report

JULY 29, 2021

Food and Drug Administration for Generally Recognized as Safe (GRAS) is being pursued. GRAS status will allow for the broad application of this novel ingredient in foods as well as dietary supplements. PCT/CA2021/050886, with a filing date of June 28, 2021. Through the Tetra partnership with Thorne HealthTech, a submission to the U.S.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

JULY 24, 2021

“The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

United Patients Group

JANUARY 5, 2023

They can be found in certain foods and supplements, including yogurt, kefir and kombucha. Probiotics also occur naturally in fermented foods such as sauerkraut and pickles. They also reduce inflammation in the body and fight off viruses and harmful germs that may enter through food or water. What are Probiotics?

Digestion 105

Digestion Research and Development Food Strains 105

Veriheal

JUNE 29, 2021

The Right to Try Act or the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act was signed into law on May 30th, 2019, according to the US Food and Drug Administration. The FDA refers to this program as the expanded access program on their website.

Therapy 64

Therapy DEA Patients Clinical Trials 64

LifeCannMD

FEBRUARY 27, 2024

The most compelling evidence of the effectiveness of Medical Marijuana in treating epilepsy comes from clinical trials. Food and Drug Administration (FDA) for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome.

Clinical Trials 59

Clinical Trials Epilepsy Marijuana Research and Development 59

Cannabis Law Report

SEPTEMBER 1, 2021

The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. Going public in November 2020 on the NEO exchange, the firm has been steadily growing its market cap and development pipeline.

Research and Development 102

Research and Development Clinical Trials Therapy Pharmaceutical 102

Cannabis Law Report

AUGUST 6, 2021

Clinical trials have shown that small doses of CBD help people to manage their social anxiety. If you just want to improve the quality of your skin, then you’ll be able to pick up CBD products at your local beauty or health foods store. CBD is believed to stimulate the production of serotonin, your brain’s feel-good chemical.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105